Technical Appendix Blood Samples
Infants with nonimmune idiopathic hydrops fetalis are not routinely checked for parvovirus B19 infection. That is why only 6 cases were available for the present study. Other causes of hydrops had been excluded, such as genetic causes and cardiovascular abnormalities.
None of the 6 mothers was an injection drug user.
Methods

B19 Recombinant Fusion Proteins
Two B19 proteins were made, viral protein VP1S (VP1-specific, VP1 aa 1-227) and VP2N (N-terminal of B19 VP2, aa 1-343). VP1S fragment was produced by PCR by using plasma B19 DNA from HIV-1-infected patient CH (1) 
B19 Immunoblot
The immunoblot method was the same as PARV4 immunoblot (2).
B19 PCR
DNA was extracted from 200 μL plasma by using High Pure Viral Nucleic Acid Kit (Roche, Mannheim, Germany). The final elution volume was 50 μl, and 5 μL was used in the reaction. B19 DNA was detected by nested PCR. The primers were P1f, P1r, n-P1f and n-P1r (3). The cycling conditions were: 94oC for 2 minute, followed by 35 cycles of 94oC for 30 sec, 55 oC for 30 sec, 72 oC for 30 sec, and a final extension of 2 min at 72 oC. The PCR products were purified by QIAquick PCR purification kit (QIAGEN) and sequenced by DyeDeoxy
Terminator Cycle Sequencing Kit (Applied Biosystems).
